Selleckchem Inc

Bio Active Compounds.

Recent products

Trastuzumab (anti-HER2)

£243.00£2,432.00 / 340.203,404.80 Standard

Bevacizumab (anti-VEGF)

£243.00£2,432.00 / 340.203,404.80 Standard

Pembrolizumab (anti-PD-1)

£243.00£2,432.00 / 340.203,404.80 Standard

Atezolizumab (anti-PD-L1)

£243.00£2,432.00 / 340.203,404.80 Standard

Ramucirumab (anti-VEGFR2)

£243.00£2,432.00 / 340.203,404.80 Standard

Nivolumab (anti-PD-1)

£243.00£2,432.00 / 340.203,404.80 Standard

Ipilimumab (anti-CTLA-4)

£243.00£2,432.00 / 340.203,404.80 Standard

Cetuximab (anti-EGFR)

£243.00£2,432.00 / 340.203,404.80 Standard

1 704 705